We are a charity and rely on donations

Charity Number: 1117194 (England and Wales)

Registered Company: 06000961

Registered address:
Shift.ms, Platform, New Station Street, LS1 4JB, United Kingdom

London office:
Shift.ms, Somerset House, Strand, West Goods Entrance, London WC2R 1LA, United Kingdom

©2026 Shift.ms

@89scott 

Last reply

89scott

Relapse 🤔

Feel like my MS has attacked me with a vengeance I feel so physically and mentally drained 😪 I need some new meds I think
First posted on the Shift.ms app
3
@St1gzy
@St1gzy
 

Sorry you're going through it mate. Definitely speak to your neuro/MS team, especially if you think this is a relapse. Might also be worth asking them about the newer high-efficacy DMTs, particularly the CD20 drugs like Ocrevus or Kesimpta, and whether you'd be suitable for one. Rebif definitely has its place, but CD20 treatment is a different league for controlling inflammatory MS. Ocrevus was actually tested head-to-head against interferon beta-1a and reduced the relapse rate by around 46–47% further. � Nice +1 Obviously every treatment has its own risks and isn't right for everyone, but if you're getting disease activity while on Rebif, I'd definitely have that conversation with your neuro rather than just suffering through it. 👍

1
@89scott
@89scott
 

Thanks for the advice mate im with my nurse in a couple of weeks so will discuss it with them